Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study

Journal of the American Society of Nephrology

Volumn 26, Issue 6, 2015, Pages 1415-1425

  Ponte, Belen ^a,b   Pruijm, Menno ^c   Ackermann, Daniel ^d   Vuistiner, Philippe ^b   Guessous, Idris ^a,b   Ehret, Georg ^a   Alwan, Heba ^b   Youhanna, Sonia ^e   Paccaud, Fred ^b   Mohaupt, Markus ^d   Péchère Bertschi, Antoinette ^a   Vogt, Bruno ^d   Burnier, Michel ^c   Martin, Pierre Yves ^a   Devuyst, Olivier ^e   Bochud, Murielle ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COPEPTIN; CREATININE; SODIUM; ARGIPRESSIN; BIOLOGICAL MARKER; GLYCOPEPTIDE;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; KIDNEY CONCENTRATING CAPACITY; KIDNEY CYST; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROLITHIASIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SODIUM URINE LEVEL; URINALYSIS; URINE OSMOLALITY; ANALYSIS OF VARIANCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FOLLOW UP; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; PHYSIOLOGY; PROCEDURES; REFERENCE VALUE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; SWITZERLAND;

ADULT; ANALYSIS OF VARIANCE; ARGININE VASOPRESSIN; BIOMARKERS; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLYCOPEPTIDES; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; LINEAR MODELS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; POLYCYSTIC KIDNEY DISEASES; REFERENCE VALUES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWITZERLAND; URINALYSIS;

EID: 84930442582     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014030260     Document Type: Article

References (66)

1. Hasler U, Leroy V, Martin PY, Féraille E: Aquaporin-2 abundance in the renal collecting duct: New insights from cultured cell models. Am J Physiol Renal Physiol 297: F10-F18, 2009
2. Wilson JL, Miranda CA, Knepper MA: Vasopressin and the regulation of aquaporin-2. Clin Exp Nephrol 17: 751-764, 2013
3. Paliege A, Roeschel T, Neymeyer H, Seidel S, Kahl T, Daigeler AL, Mutig K, Mrowka R, Ferreri NR, Wilson BS, Himmerkus N, Bleich M, Bachmann S: Group VIA phospholipase A2 is a target for vasopressin signaling in the thick ascending limb. Am J Physiol Renal Physiol 302: F865-F874, 2012
4. Mutig K, Paliege A, Kahl T, Jöns T, Müller-Esterl W, Bachmann S: Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Renal Physiol 293: F1166-F1177, 2007
5. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F: Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest 92: 2339-2345, 1993
6. Park F, Mattson DL, Skelton MM, Cowley AW Jr: Localization of the vasopressin V1a and V2 receptors within the renal cortical and medullary circulation. Am J Physiol 273: R243-R251, 1997
7. Bankir L: Antidiuretic action of vasopressin: Quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 51: 372-390, 2001
8. Miranda CA, Lee JW, Chou CL, Knepper MA: Tolvaptan as a tool in renal physiology. Am J Physiol Renal Physiol 306: F359-F366, 2014
9. Bankir L, Bouby N, Ritz E: Vasopressin: A novel target for the prevention and retardation of kidney disease? Nat Rev Nephrol 9: 223-239, 2013
10. Bouby N, Hassler C, Bankir L: Contribution of vasopressin to progression of chronic renal failure: Study in Brattleboro rats. Life Sci 65: 991-1004, 1999
11. Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH 2nd: Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 10: 363-364, 2004
12. Wang X, Wu Y, Ward CJ, Harris PC, Torres VE: Vasopressin directly regulates cyst growth in polycystic kidney disease. J Am Soc Nephrol 19: 102-108, 2008
13. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators: Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367: 2407-2418, 2012
14. El-Farhan N, Hampton D, Penney M: Measurement of arginine vasopressin. Methods Mol Biol 1065: 129-139, 2013
15. Baumann G, Dingman JF: Distribution, blood transport, and degradation of antidiuretic hormone in man. J Clin Invest 57: 1109-1116, 1976
16. Kluge M, Riedl S, Erhart-Hofmann B, Hartmann J, Waldhauser F: Improved extraction procedure and RIA for determination of arginine8-vasopressin in plasma: Role of premeasurement sample treatment and reference values in children. Clin Chem 45: 98-103, 1999
17. Morgenthaler NG, Struck J, Alonso C, Bergmann A: Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52: 112-119, 2006
18. Szinnai G, Morgenthaler NG, Berneis K, Struck J, Müller B, Keller U, Christ-Crain M: Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. J Clin Endocrinol Metab 92: 3973-3978, 2007
19. Ho TA, Godefroid N, Gruzon D, Haymann JP, Maréchal C, Wang X, Serra A, Pirson Y, Devuyst O: Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation. Kidney Int 82: 1121-1129, 2012
20. Robertson GL, Mahr EA, Athar S, Sinha T: Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52: 2340-2352, 1973
21. Preibisz JJ, Sealey JE, Laragh JH, Cody RJ, Weksler BB: Plasma and platelet vasopressin in essential hypertension and congestive heart failure. Hypertension 5: I129-I138, 1983
22. Balanescu S, Kopp P, Gaskill MB, Morgenthaler NG, Schindler C, Rutishauser J: Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States. J Clin Endocrinol Metab 96: 1046-1052, 2011
23. Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M: Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28: 219-226, 2007
24. Westermann I, Dünser MW, Haas T, Jochberger S, Luckner G, Mayr VD, Wenzel V, Stadlbauer KH, Innerhofer P, Morgenthaler N, Hasibeder WR, Voelckel WG: Endogenous vasopressin and copeptin response in multiple trauma patients. Shock 28: 644-649, 2007
25. Jochberger S, Zitt M, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dünser MW: Postoperative vasopressin and copeptin levels in noncardiac surgery patients: A prospective controlled trial. Shock 31: 132-138, 2009
26. Fenske WK, Christ-Crain M, Hörning A, Simet J, Szinnai G, Fassnacht M, Rutishauser J, Bichet DG, Störk S, Allolio B: A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis [published online ahead of print April 10, 2014]. J Am Soc Nephrol doi:10.1681/ASN.2013080895
27. Devuyst O, Torres VE: Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease. Curr Opin Nephrol Hypertens 22: 459-470, 2013
28. Pruijm M, Ponte B, Ackermann D, Vuistiner P, Paccaud F, Guessous I, Ehret G, Eisenberger U, Mohaupt M, Burnier M, Martin PY, Bochud M: Heritability, determinants and reference values of renal length: A family-based population study. Eur Radiol 23: 2899-2905, 2013
29. Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, Bertram JF: A stereological study of glomerular number and volume: Preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl (83, Suppl, Suppl): S31-S37, 2003
30. Yano M, Lin MF, Hoffman KA, Vijayan A, Pilgram TK, Narra VR: Renal measurements on CT angiograms: Correlation with graft function at living donor renal transplantation. Radiology 265: 151-157, 2012
31. Singh GR, Hoy WE: Kidney volume, blood pressure, and albuminuria: Findings in an Australian aboriginal community. Am J Kidney Dis 43: 254-259, 2004
32. Terada N, Ichioka K, Matsuta Y, Okubo K, Yoshimura K, Arai Y: The natural history of simple renal cysts. J Urol 167: 21-23, 2002
33. Al-Said J, Brumback MA, Moghazi S, Baumgarten DA, O'Neill WC: Reduced renal function in patients with simple renal cysts. Kidney Int 65: 2303-2308, 2004
34. Ravine D, Gibson RN, Donlan J, Sheffield LJ: An ultrasound renal cyst prevalence survey: Specificity data for inherited renal cystic diseases. Am J Kidney Dis 22: 803-807, 1993
35. Rule AD, Sasiwimonphan K, Lieske JC, Keddis MT, Torres VE, Vrtiska TJ: Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors. Am J Kidney Dis 59: 611-618, 2012
36. Giapros V, Tsoni C, Challa A, Cholevas V, Argyropoulou M, Papadopoulou F, Siomou E, Drougia A, Andronikou S: Renal function and kidney length in preterm infants with nephrocalcinosis: A longitudinal study. Pediatr Nephrol 26: 1873-1880, 2011
37. Grantham JJ: Acquired cystic kidney disease. Kidney Int 40: 143-152, 1991
38. Baert L, Steg A: Is the diverticulum of the distal and collecting tubules a preliminary stage of the simple cyst in the adult? J Urol 118: 707-710, 1977
39. Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A: Renal cystic diseases: A review. Adv Anat Pathol 13: 26-56, 2006
40. Chin HJ, Ro H, Lee HJ, Na KY, Chae DW: The clinical significances of simple renal cyst: Is it related to hypertension or renal dysfunction? Kidney Int 70: 1468-1473, 2006
41. Lee CT, Yang YC, Wu JS, Chang YF, Huang YH, Lu FH, Chang CJ: Multiple and large simple renal cysts are associated with prehypertension and hypertension. Kidney Int 83: 924-930, 2013
42. Hong S, Lim JH, Jeong IG, Choe J, Kim CS, Hong JH: What association exists between hypertension and simple renal cyst in a screened population? J Hum Hypertens 27: 539-544, 2013
43. Meijer E, Bakker SJ, van der Jagt EJ, Navis G, de Jong PE, Struck J, Gansevoort RT: Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6: 361-368, 2011
44. Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP: Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: Results from the CRISP cohort. Am J Kidney Dis 61: 420-429, 2013
45. Boertien WE, Meijer E, Zittema D, van Dijk MA, Rabelink TJ, Breuning MH, Struck J, Bakker SJ, Peters DJ, de Jong PE, Gansevoort RT: Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 27: 4131-4137, 2012
46. Lacquaniti A, Chirico V, Lupica R, Buemi A, Loddo S, Caccamo C, Salis P, Bertani T, Buemi M: Apelin and copeptin: Two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease. Peptides 49: 1-8, 2013
47. Meijer E, Bakker SJ, de Jong PE, Homan van der Heide JJ, van Son WJ, Struck J, Lems SP, Gansevoort RT: Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients. Transplantation 88: 561-567, 2009
48. Velho G, Bouby N, Hadjadj S, Matallah N, Mohammedi K, Fumeron F, Potier L, Bellili-Munoz N, Taveau C, Alhenc-Gelas F, Bankir L, Marre M, Roussel R: Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care 36: 3639-3645, 2013
49. Meijer E, Bakker SJ, Halbesma N, de Jong PE, Struck J, Gansevoort RT: Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int 77: 29-36, 2010
50. Enhörning S, Bankir L, Bouby N, Struck J, Hedblad B, Persson M, Morgenthaler NG, Nilsson PM, Melander O: Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: The prospective Malmö Diet and Cancer Study cardiovascular cohort. Int J Obes (Lond) 37: 598-603, 2013
51. Bhandari SS, Loke I, Davies JE, Squire IB, Struck J, Ng LL: Gender and renal function influence plasma levels of copeptin in healthy individuals. Clin Sci (Lond) 116: 257-263, 2009
52. Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AX: Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 6: 2634-2641, 2011
53. Bouby N, Bachmann S, Bichet D, Bankir L: Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat. Am J Physiol 258: F973-F979, 1990
54. Bardoux P, Bruneval P, Heudes D, Bouby N, Bankir L: Diabetes-induced albuminuria: Role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats. Nephrol Dial Transplant 18: 1755-1763, 2003
55. Bardoux P, Bichet DG, Martin H, Gallois Y, Marre M, Arthus MF, Lonergan M, Ruel N, Bouby N, Bankir L: Vasopressin increases urinary albumin excretion in rats and humans: Involvement of V2 receptors and the renin-angiotensin system. Nephrol Dial Transplant 18: 497-506, 2003
56. Gansevoort RT, Chapman AB, Czerwiec FS, Devuyst O, Grantham JJ, Higashihara E, Krasa H, Ouyang J, Perrone RD, Torres VE: The effect of tolvaptan on albuminuria in ADPKD. Results of the TEMPO 3:4 trial [Abstract]. J Am Soc Nephrol 24: 688A, 2013
57. Olsburgh J, Thomas K, Wong K, Bultitude M, Glass J, Rottenberg G, Silas L, Hilton R, Koffman G: Incidental renal stones in potential live kidney donors: Prevalence, assessment and donation, including role of ex vivo ureteroscopy. BJU Int 111: 784-792, 2013
58. Kanno T, Kubota M, Sakamoto H, Nishiyama R, Okada T, Higashi Y, Yamada H: The efficacy of ultrasonography for the detection of renal stone. Urology 84: 285-288, 2014
59. de Boer H, Roelofsen A, Janssens PM: Antidiuretic hormone antagonist to reduce cystine stone formation. Ann Intern Med 157:459-460, 2012
60. Al-Said J, O'Neill WC: Reduced kidney size in patients with simple renal cysts. Kidney Int 64: 1059-1064, 2003
61. Ponte B, Pruijm M, Ackermann D, Vuistiner P, Eisenberger U, Guessous I, Rousson V, Mohaupt MG, Alwan H, Ehret G, Pechere-Bertschi A, Paccaud F, Staessen JA, Vogt B, Burnier M, Martin PY, Bochud M: Reference values and factors associated with renal resistive index in a family-based population study. Hypertension 63: 136-142, 2014
62. Nahm AM, Ritz E: The simple renal cyst. Nephrol Dial Transplant 15: 1702-1704, 2000
63. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
64. Mattix HJ, Hsu CY, Shaykevich S, Curhan G: Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race. J Am Soc Nephrol 13: 1034-1039, 2002
65. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, Jin Y, Olszanecka A, Malyutina S, Casiglia E, Filipovský J, Kawecka-Jaszcz K, Nikitin Y, Staessen JA; European Project on Genes in Hypertension (EPOGH) Investigators: Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305: 1777-1785, 2011
66. Bochud M, Elston RC, Maillard M, Bovet P, Schild L, Shamlaye C, Burnier M: Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean). Kidney Int 67: 61-69, 2005